Boceprevir - CAS# 394730-60-0 0127 with EC50s of 0

with EC50s of 0

Formula: C13H8N2O3

Chemical Name: 6-[(2S

GNF-2 dose-dependently inhibited the proliferation of osteoclast precursors through the suppression of the M-CSFR c-Fms

and cholesterol homoeostasis

Boceprevir - CAS# 394730-60-0 0127 with EC50s of 0Boceprevir (INN, trade name Victrelis), CAS No. 394730 60 0, is a protease inhibitor used as a treatment for hepatitis C genotype 1. It binds to HCV nonstructural 3 NS3 (HCV) active site. It was being developed by Schering Plough, but is now being developed by Merck since Schering was acquired in 2009. It was approved by the FDA on May 13, 2011. Product information CAS Number: 394730 60 0 Molecular Weight: 519. 68 Formula: C27H45N5O5 Synonym: EBP 520